Literature DB >> 6854270

17D yellow fever virus infection of P388D1 cells mediated by monoclonal antibodies: properties of the macrophage Fc receptor.

J J Schlesinger, M W Brandriss.   

Abstract

Thirteen IgG monoclonal antibodies to the envelope protein of 17D yellow fever virus (17D YF) were produced. All of the antibodies, whether type-specific to 17D YF or flavivirus cross-reactive, mediated antibody-dependent enhancement (ADE) of virus growth in P388D1 cells. There was no consistent relationship between ADE titres and the degree or pattern of neutralizing and/or haemagglutination inhibition activity. Monoclonal antibodies of different isotypes were used to investigate further the properties of P388D1 Fc receptors. The effects of trypsin treatment of P388D1 on ADE were similar to those previously described in experiments measuring direct binding of IgG proteins or rosetting of sheep red blood cells (SRBC) by macrophages, demonstrating sensitivity to digestion by trypsin of the Fc receptor for monomeric IgG2a but not for IgG2b. Aggregated myeloma proteins of IgG2a and IgG2b isotypes competed equally well with either IgG2a or IgG2b monoclonal antibodies to 17D YF in inhibition of ADE. However, selective inhibition by the homologous isotype was observed when rosetting by P388D1 of SRBC coated with IgG2a or IgG2b monoclonal antibodies was examined. These results may help to explain apparent discrepancies previously reported between experiments utilizing direct binding of IgG proteins and those using rosetting of antibody-coated SRBC to examine Fc receptor properties and indicate that immune complexes of virus and antibody resemble aggregated immunoglobulins with respect to macrophage Fc receptor function and differ from antibody-coated SRBCs.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6854270     DOI: 10.1099/0022-1317-64-6-1255

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Characterization of a siberian virus isolated from a patient with progressive chronic tick-borne encephalitis.

Authors:  T S Gritsun; T V Frolova; A I Zhankov; M Armesto; S L Turner; M P Frolova; V V Pogodina; V A Lashkevich; E A Gould
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q.

Authors:  Kristina von Kietzell; Tanja Pozzuto; Regine Heilbronn; Tobias Grössl; Henry Fechner; Stefan Weger
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

3.  Infection-enhancing and -neutralizing activities of mouse monoclonal antibodies against dengue type 2 and 4 viruses are controlled by complement levels.

Authors:  Atsushi Yamanaka; Saori Kosugi; Eiji Konishi
Journal:  J Virol       Date:  2007-11-14       Impact factor: 5.103

4.  Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophages.

Authors:  C W Olsen; W V Corapi; C K Ngichabe; J D Baines; F W Scott
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

5.  Two receptors are required for antibody-dependent enhancement of human immunodeficiency virus type 1 infection: CD4 and Fc gamma R.

Authors:  A Takeda; R W Sweet; F A Ennis
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

6.  Flavivirus-induced antibody cross-reactivity.

Authors:  Karen L Mansfield; Daniel L Horton; Nicholas Johnson; Li Li; Alan D T Barrett; Derek J Smith; Sareen E Galbraith; Tom Solomon; Anthony R Fooks
Journal:  J Gen Virol       Date:  2011-09-07       Impact factor: 3.891

Review 7.  Biomarkers in Japanese encephalitis: a review.

Authors:  Ravi Kant Upadhyay
Journal:  Biomed Res Int       Date:  2013-12-18       Impact factor: 3.411

8.  Ross River Virus Immune Evasion Strategies and the Relevance to Post-viral Fatigue, and Myalgic Encephalomyelitis Onset.

Authors:  Brett A Lidbury
Journal:  Front Med (Lausanne)       Date:  2021-03-24

Review 9.  Pathogenesis of flavivirus encephalitis.

Authors:  Thomas J Chambers; Michael S Diamond
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

10.  Impact of yellow fever virus envelope protein on wild-type and vaccine epitopes and tissue tropism.

Authors:  Emily H Davis; Binbin Wang; Mellodee White; Yan-Jang S Huang; Vanessa V Sarathy; Tian Wang; Nigel Bourne; Stephen Higgs; Alan D T Barrett
Journal:  NPJ Vaccines       Date:  2022-03-23       Impact factor: 9.399

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.